Need more data on Oxford’s Covid-19 vaccine to back its efficacy: WHO

Prashasti Awasthi Mumbai | Updated on November 30, 2020 Published on November 30, 2020

According to The World Health Organisation’s top scientist Dr Soumya Swaminathan, the multilateral organisation requires more data to support the efficacy of the coronavirus vaccine developed by Oxford University and AstraZeneca, as per media reports.

This comes as Oxford and AstraZeneca announced last week that their vaccine appeared 62 per cent effective in people who received two doses and 90 per cent effective when volunteers were given a half dose followed by a full dose.

Later, they stated that they faced a manufacturing issue had led to a half dose wrongly administered as the first dose to some participants.

ALSO READ: Serendipity and science aside, AZ-Oxford to evaluate ‘shortened’ dosing regimen on Covid-19 vaccine candidate

Briefing the press on Friday, Soumya Swaminathan, WHO’s chief scientist, said: “The numbers are too small to really come to any definitive conclusions. It’s hard to compare these two groups.”

She added that the WHO had come to know that AstraZeneca would like to conduct a full study testing the half dose followed by a full-dose regimen. She noted that the other ongoing research evaluating the vaccine uses two full doses.

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

Published on November 30, 2020
This article is closed for comments.
Please Email the Editor